Gut Microbiota Analysis in Postoperative Lynch Syndrome Patients.

16S sequencing Lynch syndrome fecal biomarkers fecal microbiota hereditary cancer predisposition

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2019
Historique:
received: 21 02 2019
accepted: 15 07 2019
entrez: 17 8 2019
pubmed: 17 8 2019
medline: 17 8 2019
Statut: epublish

Résumé

Lynch syndrome (LS) is a dominantly inherited condition with incomplete penetrance, characterized by high predisposition to colorectal cancer (CRC), endometrial and ovarian cancers, as well as to other tumors. LS is associated with constitutive DNA mismatch repair (MMR) gene defects, and carriers of the same pathogenic variants can show great phenotypic heterogeneity in terms of cancer spectrum. In the last years, human gut microbiota got a foothold among risk factors responsible for the onset and evolution of sporadic CRC, but its possible involvement in the modulation of LS patients' phenotype still needs to be investigated. In this pilot study, we performed 16S rRNA gene sequencing of bacterial DNA extracted from fecal samples of 10 postoperative LS female patients who had developed colonic lesions (L-CRC) or gynecological cancers (L-GC). Our preliminary data show no differences between microbial communities of L-CRC and L-GC patients, but they plant the seed of the possible existence of a fecal microbiota pattern associated with LS genetic background, with

Identifiants

pubmed: 31417532
doi: 10.3389/fmicb.2019.01746
pmc: PMC6682596
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1746

Références

Am J Hum Genet. 2001 Jan;68(1):118-127
pubmed: 11112663
Mol Microbiol. 2001 Nov;42(3):729-40
pubmed: 11722738
Cancer Res. 2006 Aug 1;66(15):7810-7
pubmed: 16885385
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4516-22
pubmed: 20534432
Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19786-91
pubmed: 23150581
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Nat Genet. 2014 Feb;46(2):107-115
pubmed: 24362816
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Commun. 2015 Mar 11;6:6528
pubmed: 25758642
Gut. 2017 Jan;66(1):70-78
pubmed: 26408641
Nat Commun. 2015 Oct 30;6:8727
pubmed: 26515465
Oncotarget. 2016 Jun 14;7(24):37132-37144
pubmed: 27206798
Oncotarget. 2016 Jul 19;7(29):46158-46172
pubmed: 27323816
Clin Cancer Res. 2017 Apr 15;23(8):2061-2070
pubmed: 27697996
Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):404-412
pubmed: 27799157
Microbiome. 2016 Nov 25;4(1):62
pubmed: 27884206
Microb Cell Fact. 2017 May 8;16(1):79
pubmed: 28482838
Gut. 2018 Jul;67(7):1306-1316
pubmed: 28754778
BMJ Open Gastroenterol. 2017 Jul 3;4(1):e000145
pubmed: 28944067
Microbiome. 2017 Nov 16;5(1):150
pubmed: 29145893
Science. 2018 Feb 2;359(6375):592-597
pubmed: 29420293
CA Cancer J Clin. 2018 May;68(3):217-231
pubmed: 29485237
Front Microbiol. 2018 Mar 06;9:346
pubmed: 29559959
Best Pract Res Clin Gastroenterol. 2017 Dec;31(6):643-648
pubmed: 29566907
Methods Mol Biol. 2018;1765:139-153
pubmed: 29589305
Sci Rep. 2018 Jul 9;8(1):10329
pubmed: 29985435
Sci Rep. 2018 Sep 18;8(1):13974
pubmed: 30228361
Genome Med. 2018 Oct 31;10(1):78
pubmed: 30376889
Cell Rep. 2019 Jan 2;26(1):222-235.e5
pubmed: 30605678

Auteurs

Giorgia Mori (G)

Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.

Beatrice Silvia Orena (BS)

Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.

Ilenia Cultrera (I)

Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.

Giulia Barbieri (G)

Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.

Alessandra M Albertini (AM)

Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.

Guglielmina Nadia Ranzani (GN)

Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.
Research Center for the Study of Hereditary and Familial Tumors, University of Insubria, Varese, Italy.

Ileana Carnevali (I)

Research Center for the Study of Hereditary and Familial Tumors, University of Insubria, Varese, Italy.
Department of Pathology, ASST-Sette Laghi, Varese, Italy.

Maria Grazia Tibiletti (MG)

Research Center for the Study of Hereditary and Familial Tumors, University of Insubria, Varese, Italy.
Department of Pathology, ASST-Sette Laghi, Varese, Italy.

Maria Rosalia Pasca (MR)

Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.

Classifications MeSH